Navigation Links
Cord Blood Registry Maintains Solid Growth in First Quarter 2009
Date:6/11/2009

Continued Market Share Increase Combined with Significant Operating Efficiencies Lead to Jump in Earnings

SAN BRUNO, Calif., June 11 /PRNewswire/ -- Cord Blood Registry (CBR), the global leader in the collection and preservation of newborn stem cells from umbilical cord blood, reported solid revenue growth in first quarter 2009, up nearly 20 percent compared to first quarter 2008. Earnings for the quarter showed even stronger gains due to increases in both volume and market share coupled with more efficient operations.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090326/SF89756LOGO)

"Despite a minor impact from the current state of the economy, our business has continued to increase and our financial position is extremely strong," said Tom Moore, chief executive officer. "We anticipate that we'll see accelerated growth through the year as the economy recovers."

The company points to the industry-leading quality of its product and extremely high customer satisfaction as two key factors that have helped drive the company's growth in market share during the past five quarters from about 40 percent to near 50 percent.

"Cord Blood Registry continues to lead the newborn stem cell banking industry through an intense focus on superior quality and customer service," said Moore. "We ask every parent who entrusts us with preserving their newborn's cord blood to give us a report card. We're extremely proud to maintain a satisfaction score above 99 percent, which we believe has helped drive our market share growth."

In addition, the company continues to realize the benefit of reinvesting earnings back into the business to further enhance operations at its wholly-owned, state-of-the-art laboratory facility and maintain the industry-leading quality of its product. This includes the company's complete conversion in 2008 to automated processing technology as part of its propriety CellAdvantage(R) system.

"Every parent who banks with CBR can expect that their newborn's stem cells will be individually transported via specialized courier service from time of birth to our laboratory in less than 22 hours on average. Once the cells arrive, our proprietary collection and automated processing system gives us the unique ability to recover and store more than 98 percent of the available stem cells, which is up to 60 percent more than others" said Johnnie Domingue, chief financial officer and chief operating officer. "We're not aware of any other stem cell bank in the world that can offer this level of service, quality and efficiency."

About Cord Blood Registry

Cord Blood Registry(R) (CBR(R)) is the world's largest stem cell bank, focused on the collection, processing and storage of newborn stem cells from umbilical cord blood and ensuring their viability for medical use. CBR is the most recommended family cord blood bank by obstetricians and was the first family bank accredited by AABB (formerly the American Association of Blood Banks). The company has been profitable and cash flow positive from operations on a cumulative basis since 1999. To date, CBR has processed and stored cord blood units for more than 275,000 newborns from around the world and has released more client cord blood units for specific therapeutic use than any other family cord blood bank. The company's research and development efforts are focused on helping the world's leading clinical researchers advance regenerative medical therapies using cord blood stem cells as well as enhancing its industry-leading technical innovations for stem cell collection, processing and storage that optimize quality and cell yield. For more information, visit www.CordBlood.com.


'/>"/>
SOURCE Cord Blood Registry
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cord Blood America Continuing European Expansion
2. Trimming the fat boosts blood recovery after marrow transplant
3. M.A.Z.E. Cord Blood Laboratories Offers Expectant Parents The Chance To Win A $500 Savings Bond
4. New Survey Finds Majority of Adults Dont Understand a Key Source of High Blood Pressure
5. Another Blood Fat Fuels Heart Attack Risk
6. RainEarth Applies for Patent for Second Generation Blood Dialysis Equipment
7. Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier
8. VIVUS Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes
9. Lack of Sleep Can Raise Blood Pressure Over Time
10. Automated Artificial Pancreas Controls Blood Glucose Levels in Diabetes Patients for First Time
11. Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , Belgium , June ... MKT: VNRX), today announced the appointment of Dr. ... of Directors as a Non-Executive Director, effective June ... Company,s Audit, Compensation and Nominations and Governance Committees.  ... Dr. Futcher will provide independent expertise and strategic ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
Breaking Medicine Technology: